Chen et al. proposed a 3-gene signature (SULT1E1, IGF2BP3, and MAP4K4) based on DNA methylation data that predicts poorer overall survival of pancreatic cancer (23). The gene discussed is IGF2BP3; the disease is familial pancreatic carcinoma.